Article
Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
Current Alzheimer research - 1 Jan 2014
Macdonald I R, DeBay D R, Reid G A, O'Leary T P, Jollymore C T, Mawko G, Burrell S, Martin E, Bowen C V, Brown R E, Darvesh S
Abstract excerpt
Brain glucose hypometabolism has been observed in Alzheimer's disease (AD) patients, and is detected with (18)F radiolabelled glucose, using positron emission tomography. A pathological hallmark of AD is deposition of brain β- amyloid plaques that may influence cerebral glucose metabolism. The five times familial AD (5XFAD) mouse is a model of brain amyloidosis exhibiting AD-like phenotypes. This study examines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
